Pro-Neuron, Inc.
31Patents
0Active
31Granted
36Portfolio score
Filing activity: Jul 13, 1992 → Jun 4, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6218519A | Compounds and methods for the selective treatment of cancer and bacterial infections | Chemistry; Metallurgy | 90 | Expired |
| US6022848A | Inhibitor of stem cell proliferation and uses thereof | Chemistry; Metallurgy | 62 | Expired |
| US6472378B2 | Compositions and methods for treatment of mitochondrial diseases | Chemistry; Metallurgy | 55 | Expired |
| US5736531A | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides | Chemistry; Metallurgy | 49 | Expired |
| US5968914A | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | Emerging Cross-Sectional Technologies | 47 | Expired |
| US5470838A | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine | Chemistry; Metallurgy | 41 | Expired |
| US5691320A | Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis | Chemistry; Metallurgy | 34 | Expired |
| US5770582A | Pharmaceutical compositions containing deoxyribonucleosides for wound healing | Chemistry; Metallurgy | 34 | Expired |
| US5246708A | Methods for promoting wound healing with deoxyribonucleosides | Chemistry; Metallurgy | 29 | Expired |
| US5583117A | Acylated uridine and cytidine for elevating tissue uridine and cytidine | Chemistry; Metallurgy | 24 | Expired |
| US6344447B1 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6258795A | Acylated uridine and cytidine and uses thereof | Chemistry; Metallurgy | 21 | Expired |
| US5861483A | Inhibitor of stem cell proliferation and uses thereof | Human Necessities | 20 | Expired |
| US6297222A | Acyl deoxyribonucleoside derivatives and uses thereof | Chemistry; Metallurgy | 18 | Expired |
| US6316426A | Acylated uridine and cytidine and uses thereof | Chemistry; Metallurgy | 17 | Expired |
| US6020322A | Acyl deoxyribonucleoside derivatives and uses thereof | Chemistry; Metallurgy | 13 | Expired |
| US6274563A | Acylated uridine and cytidine and uses thereof | Chemistry; Metallurgy | 12 | Expired |
| US6060459A | Enhancing blood cell count with oxypurine nucleosides | Chemistry; Metallurgy | 10 | Expired |
| US6232298A | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis | Chemistry; Metallurgy | 10 | Expired |
| US6020320A | Acyl deoxyribonucleoside derivatives and uses thereof | Chemistry; Metallurgy | 10 | Expired |
| US5939391A | Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation | Electricity | 8 | Expired |
| US6255290A | Antimutagenic compositions for treatment and prevention of photodamage to skin | Human Necessities | 5 | Expired |
| US6054441A | Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis | Chemistry; Metallurgy | 5 | Expired |
| US6090782A | Hemoglobin alpha and beta chain peptide fragments useful for inhibiting stem cell proliferation | Electricity | 5 | Expired |
| US6403565B1 | Antimutagenic compositions for treatment and prevention of photodamage to skin | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.